SAFETY AND IMMUNOGENICITY OF COMBINED RABIES AND TYPHOID-FEVER IMMUNIZATION

被引：6
|
作者：
FRITZELL, C
ROLLIN, PE
TOUIR, M
SUREAU, P
TEULIERES, L
机构：
[1] HOP INST PASTEUR,CTR ANTIRABIQUE,25 RUE DOCTEUR ROUX,F-75015 PARIS,FRANCE
[2] PASTEUR MERIEUX SERUMS & VACCINS,F-92430 MARNES COQUETTE,FRANCE
来源：
VACCINE | 1992年 / 10卷 / 05期
关键词：
RABIES; TYPHOID FEVER; COMBINED IMMUNIZATION; IMMUNOGENICITY; SIDE EFFECTS;
D O I：
10.1016/0264-410X(92)90366-R
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The prevalence of rabies and typhoid fever in many developing countries poses a serious health hazard to travellers. The development of a combined immunization schedule would be advantageous. A study was performed on 104 adult volunteers using purified Vero cell rabies vaccine and Typhim Vi, a purified capsular polysaccharide, either separately or in combination. No significant difference was observed in immunogenicity or tolerance between the two groups. A 3-year follow-up study is planned.
引用
收藏
页码：299 / 300
页数：2
相关论文
共 50 条
12345